Wellington Management Group’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154M | Sell |
1,629,848
-501,654
| -24% | -$47.4M | 0.03% | 420 |
|
|
2025
Q1 | $135M | Sell |
2,131,502
-893,739
| -30% | -$56.7M | 0.03% | 442 |
|
|
2024
Q4 | $140M | Buy |
3,025,241
+1,146,609
| +61% | +$53.2M | 0.03% | 454 |
|
|
2024
Q3 | $54M | Buy |
1,878,632
+307,272
| +20% | +$8.84M | 0.01% | 677 |
|
|
2024
Q2 | $22.7M | Sell |
1,571,360
-2,338,106
| -60% | -$33.8M | ﹤0.01% | 913 |
|
|
2024
Q1 | $62.9M | Buy |
3,909,466
+125,472
| +3% | +$2.02M | 0.01% | 645 |
|
|
2023
Q4 | $75.2M | Sell |
3,783,994
-683,577
| -15% | -$13.6M | 0.01% | 621 |
|
|
2023
Q3 | $72.8M | Buy |
4,467,571
+164,268
| +4% | +$2.68M | 0.01% | 610 |
|
|
2023
Q2 | $91M | Buy |
4,303,303
+1,011,830
| +31% | +$21.4M | 0.02% | 572 |
|
|
2023
Q1 | $66.1M | Sell |
3,291,473
-54,897
| -2% | -$1.1M | 0.01% | 630 |
|
|
2022
Q4 | $87.4M | Sell |
3,346,370
-830,906
| -20% | -$21.7M | 0.02% | 553 |
|
|
2022
Q3 | $42.7M | Buy |
4,177,276
+349,127
| +9% | +$3.57M | 0.01% | 709 |
|
|
2022
Q2 | $16M | Buy |
3,828,149
+49,364
| +1% | +$207K | ﹤0.01% | 1004 |
|
|
2022
Q1 | $18.9M | Sell |
3,778,785
-1,053,203
| -22% | -$5.26M | ﹤0.01% | 1033 |
|
|
2021
Q4 | $32.5M | Buy |
4,831,988
+537,950
| +13% | +$3.61M | 0.01% | 962 |
|
|
2021
Q3 | $23.5M | Buy |
4,294,038
+382,198
| +10% | +$2.09M | ﹤0.01% | 1049 |
|
|
2021
Q2 | $25.6M | Buy |
3,911,840
+113,699
| +3% | +$744K | ﹤0.01% | 1033 |
|
|
2021
Q1 | $31.8M | Buy |
3,798,141
+2,552,442
| +205% | +$21.3M | 0.01% | 946 |
|
|
2020
Q4 | $8.72M | Buy |
+1,245,699
| New | +$8.72M | ﹤0.01% | 1215 |
|